Newsfeeds - Spark Newswire

1 minute read

Piper Sandler Initiates Coverage On Verona Pharma with Overweight Rating, Announces Price Target of $31

Today, 1:58 PM

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Verona Pharma (NASDAQ:VRNA) with a Overweight rating and announces Price Target of $31.

VRNA

2 minute read

Recap Of Friday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

Today, 1:58 PM

The U.S. Food and Drug Administration (FDA) has approved Axsome Therapeutics’ (NASDAQ:AXSM) lead asset AUVELITY (dextromethorphan HBr -bupropion HCl)…

AXSM

4 minute read

Biotech Daily: Cancer Causing Impurities In Merck’s Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon’s Monkeypox Trial

By Vandana Singh

Today, 1:58 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADMP

9 minute read

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:58 PM

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

AEL

3 minute read

Recap of Tuesday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

Today, 1:58 PM

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Relmada Therapeutics’ (NASDAQ:RLMD) lead asset…

BGNE

3 minute read

Dow Drops Over 100 Points; Verona Pharma Shares Jump

By Lisa Levin

Today, 1:58 PM

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 100 points on Tuesday.

ATRA

3 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 1:58 PM

ATRA

6 minute read

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 1:58 PM

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.

AEL

3 minute read

Nasdaq Tumbles 1.5%; BBQ Holdings Shares Spike Higher

By Lisa Levin

Today, 1:58 PM

U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 1.5% on Tuesday.

AYTU

2 minute read

Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday

By Lisa Levin

Today, 1:58 PM

Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.

AEL